Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 2NETWORK 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 63Breast Neoplasms 63Carcinoma, Non-Small-Cell Lung 39Triple Negative Breast Neoplasms 29Ovarian Neoplasms 25Fallopian Tube Neoplasms 22Squamous Cell Carcinoma of Head and Neck 17Lung Neoplasms 16Stomach Neoplasms 11Neoplasm Metastasis 11Neoplasms 9Inflammatory Breast Neoplasms 9Breast Neoplasms, Male 9Melanoma 7Esophageal Neoplasms 7Cholangiocarcinoma 7Uterine Cervical Neoplasms 6Esophageal Squamous Cell Carcinoma 6Endometrial Neoplasms 6Carcinoma, Ovarian Epithelial 6Pancreatic Adenocarcinoma 5Gallbladder Neoplasms 5Adenocarcinoma Of Esophagus 5Adenocarcinoma 5Urinary Bladder Neoplasms 4Recurrence 4Carcinoma, Transitional Cell 4Biliary Tract Neoplasms 4Prostatic Neoplasms 3Peritoneal Neoplasms 3

Interventions

linrodostat 1Taxes 1Paclitaxel 1Nivolumab 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Endometrial Adenocarcinoma × Taxes × Clear all
NCT01041027 2023-10-26

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
31 enrolled 8 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡